Skip to main content

Table 6 Relationship between demographic/histopathologic features and pre-NAC tumor SULpeak

From: Role of 18 fluorine-fluorodeoxyglucose positron emission tomography/computed tomography in assessment of neoadjuvant chemotherapy response in breast cancer patients

Characteristics

Pre-NAC tumor SULpeak

P value

Mean

SD

Range

Median

Age (years)

     

 ≤ median 54

6.6

4.3

2.5–15

5.2

a0.215

 > median 54

7.5

3.1

2.8–13.7

7.6

 

Menopausal status

     

 Pre-menopause

6.6

4.3

2.5–15

5.1

a0.341

 Post-menopause

7.3

3.5

2.5–14.1

6.7

 

Tumor grade

     

 II

6.5

3.5

2.5–14.1

5.4

a0.573

 III

7.6

4.3

2.5–15

6.6

 

Tumor molecular type

     

 Luminal A

6.1

3.4

2.5–14.1

5.1

b0.549

 Luminal B

7.3

2.6

4.7–12

6.9

 

 HER-2 +

6.9

5.6

2.8–15

5.1

 

 Basal type

9.2

4.7

4.5–14.4

9.1

 
  1. a Mann-Whitney U test
  2. b Kruskal-Wallis test (KW)